Home LiteratureArticle Details
PMID: 6619736 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Formation of a novel phagosome by the Legionnaires' disease bacterium (Legionella pneumophila) in human monocytes.

The Journal of experimental medicine ·Vol. 158 ·No. 4 ·1983-10-01 ·Pages 1319-31

Horwitz MA

Abstract

Previous studies have shown that L. pneumophila multiplies intracellularly in human monocytes and alveolar macrophages within a membrane-bound cytoplasmic vacuole studded with ribosomes. In this paper, the formation of this novel vacuole is examined. After entry into monocytes, L. pneumophila resides in a membrane-bound vacuole. During the first hour after entry, vacuoles containing L. pneumophila are found surrounded by smooth vesicles fusing with or budding off from the vacuolar membrane and by mitochondria closely apposed to the vacuolar membrane. By 4 h, vacuoles are found less frequently surrounded by these cytoplasmic organelles, but now ribosomes and rough vesicles are found gathered about the vacuole. By 8 h, the ribosome-lined vacuole has formed. Erythromycin, at concentrations that completely inhibit the intracellular multiplication of L. pneumophila, has no effect on vacuole formation. Formalin-killed L. pneumophila also reside in a membrane-bound vacuole after entry into monocytes. In contrast to the situation with live L. pneumophila, cytoplasmic organelles are not found surrounding vacuoles containing formalin-killed L. pneumophila at any time after entry. Formalin-killed bacteria are rapidly digested, and by 4 h, few remain intact. The L. pneumophila-containing vacuole has certain features in common with other intracellular organisms that inhibit phagosome-lysosome fusion; these organisms may share a common mechanism for vacuole formation and inhibition of phagosome-lysosome fusion.

MeSH Terms
Adult Cells, Cultured Erythromycin/pharmacology Formaldehyde/pharmacology Humans Legionella/growth & development,physiology,ultrastructure Legionnaires' Disease/drug therapy,immunology,microbiology Monocytes/immunology,physiology,ultrastructure Organoids/ultrastructure Phagocytosis Ribosomes/ultrastructure Time Factors Vacuoles/classification,drug effects,ultrastructure
Chemicals
Formaldehyde Erythromycin
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Horwitz M A
References (9)
9 references, click to expand
  1. Ultrastructure of human leukocytes after simultaneous fixation with glutaraldehyde and osmium tetroxide and "postfixation" in uranyl acetate.
    J Cell Biol. 1968 Sep;38(3):615-27 PMID: 4874495
  2. Interaction of L cells and Chlamydia psittaci: entry of the parasite and host responses to its development.
    J Bacteriol. 1972 May;110(2):706-21 PMID: 4336694
  3. The interaction between Toxoplasma gondii and mammalian cells. II. The absence of lysosomal fusion with phagocytic vacuoles containing living parasites.
    J Exp Med. 1972 Nov 1;136(5):1173-94 PMID: 4343243
  4. Interactions of TRIC agents with macrophages and BHK-21 cells observed by electron microscopy.
    J Hyg (Lond). 1973 Sep;71(3):515-28 PMID: 4518351
  5. Ultrastructure of lung in Legionnaires' disease. Observations of three biopsies done during the Vermont epidemic.
    Ann Intern Med. 1979 Apr;90(4):555-9 PMID: 434634
  6. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.
    J Clin Invest. 1980 Jan;65(1):82-94 PMID: 6985617
  7. Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes.
    J Clin Invest. 1980 Sep;66(3):441-50 PMID: 7190579
  8. Intracellular multiplication of Legionnaires' disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampin.
    J Clin Invest. 1983 Jan;71(1):15-26 PMID: 6848556
  9. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy.
    J Cell Biol. 1963 Apr;17:208-12 PMID: 13986422
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1983-10-01
Pages
1319-31
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2187375
Subset
IM
Grants
NIAID NIH HHS · AI 17254 · United States
NCRR NIH HHS · S07 RR07065 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com